Get the Stockscreener App
4.93
1.60%
-0.08
After Hours:
4.76
-0.17
-3.45%
Lyra Therapeutics Inc Stock (LYRA) Forecast
The Lyra Therapeutics Inc (LYRA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.7278, representing a -44.67% decrease from the current price of $4.93. The highest analyst price target is $3.2933, and the lowest is $2.1624.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LYRA Price Target
Average 3.0352
(-38.43% Downside)
Is Lyra Therapeutics Inc (LYRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.13 | Neutral |
| STOCH(9,6) | 23.07 | Neutral |
| STOCHRSI(14) | 64.53 | Neutral |
| MACD(12,26) | -0.2361 | Buy |
| ADX(14) | 29.60 | Buy |
| William %R | -75.47 | Neutral |
| CCI(14) | -8.8698 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.838
Buy
|
4.8268
Buy
|
| MA20 |
4.981
Sell
|
4.9695
Sell
|
| MA50 |
5.4882
Sell
|
5.7587
Sell
|
| MA100 |
7.5252
Sell
|
8.6017
Sell
|
| MA200 |
9.8551
Sell
|
31.61
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, LYRA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 8 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on LYRA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.13 indicates that LYRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.07 indicates that LYRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.53 indicates that LYRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.6 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -8.8698 indicates that LYRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LYRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lyra Therapeutics Inc financial reports and earnings history, Lyra Therapeutics Inc (LYRA) stock could reach $14.15 by 2030, $31.03 by 2040 and $39.64 by 2050. See the projected annual prices until 2050 of the Lyra Therapeutics Inc stock below:
- Lyra Therapeutics Inc (LYRA) is expected to reach an average price of $22.24 in 2035, with a high prediction of $21.62 and a low estimate of $20.88. This indicates an $351.10% rise from the last recorded price of $4.93.
- Lyra Therapeutics Inc (LYRA) stock is projected to chart a bullish course in 2040, with an average price target of $31.30, representing an $534.90% surge from its current level. The forecast ranges from a conservative $31.23 to a sky-high $31.03.
- Our analysts predict Lyra Therapeutics Inc (LYRA) to jump 572.77% by 2045, soaring from $33.48 to an average price of $33.17, potentially reaching $34.23. While $33.48 is the low estimate, the potential upside is significant.
- Lyra Therapeutics Inc (LYRA) stock is expected to climb by 2050, reaching an average of $38.92, a $689.48% jump from its current level. However, a wide range of estimates exists, with high and low targets of $39.64 and $38.95, respectively, highlighting the market's uncertainty.
Lyra Therapeutics Inc Stock (LYRA) Year by Year Forecast
Lyra Therapeutics Inc Stock (LYRA) Price Forecast for 2025
Lyra Therapeutics Inc Stock (LYRA) is expected to reach an average price of $2.6118 in 2025, with a high prediction of $5.1232 and a low estimate of $0.1004. This indicates an -47.02% fall from the last recorded price of $4.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $2.0724 | $2.1624 | $3.2933 | -57.96% |
| August, 2025 | $2.4813 | $2.7672 | $2.1716 | -49.67% |
| September, 2025 | $3.4502 | $3.3311 | $3.5205 | -30.02% |
| October, 2025 | $2.1189 | $2.9589 | $3.2797 | -57.02% |
| November, 2025 | $0.9238 | $0.9478 | $1.5686 | -81.26% |
| December, 2025 | $2.5464 | $0.8675 | $1.8467 | -48.35% |
Lyra Therapeutics Inc Stock (LYRA) Price Forecast for 2026
The predicted value for Lyra Therapeutics Inc (LYRA) in 2026 is set at an average of $3.4332. Estimates vary from a peak of $5.2028 to a trough of $1.6635, indicating an -30.36% surge from the present price of $4.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.1353 | $3.0458 | $3.7053 | -16.12% |
| February, 2026 | $4.8142 | $4.255 | $4.6142 | -2.35% |
| March, 2026 | $5.4131 | $5.2937 | $4.8631 | +9.80% |
| April, 2026 | $4.3817 | $4.5917 | $5.2028 | -11.12% |
| May, 2026 | $4.2306 | $4.2306 | $4.2715 | -14.19% |
| June, 2026 | $4.8195 | $4.4798 | $4.2702 | -2.24% |
| July, 2026 | $2.9882 | $3.3784 | $4.5493 | -39.39% |
| August, 2026 | $2.7471 | $3.2268 | $2.7148 | -44.28% |
| September, 2026 | $2.8257 | $3.2265 | $2.7457 | -42.68% |
| October, 2026 | $2.4646 | $2.6946 | $2.5354 | -50.01% |
| November, 2026 | $1.3535 | $1.6635 | $1.9343 | -72.55% |
| December, 2026 | $1.6021 | $2.0132 | $1.9327 | -67.50% |
Lyra Therapeutics Inc Stock (LYRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lyra Therapeutics Inc (LYRA) is $3.1364, with a high forecast of $4.2636 and a low forecast of $2.0092. This indicates an -36.38% decrease from the last price of $4.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.791 | $2.1604 | $2.1063 | -43.39% |
| February, 2027 | $2.7399 | $2.7599 | $2.4365 | -44.42% |
| March, 2027 | $3.7186 | $2.7897 | $3.2673 | -24.57% |
| April, 2027 | $3.9474 | $3.8883 | $4.099 | -19.93% |
| May, 2027 | $4.1564 | $4.0169 | $3.9264 | -15.69% |
| June, 2027 | $4.175 | $4.0905 | $4.065 | -15.31% |
| July, 2027 | $4.5439 | $4.3342 | $4.1954 | -7.83% |
| August, 2027 | $4.0328 | $4.3328 | $4.2636 | -18.20% |
| September, 2027 | $3.5114 | $3.6214 | $3.9322 | -28.77% |
| October, 2027 | $3.2203 | $3.4003 | $3.371 | -34.68% |
| November, 2027 | $1.7492 | $2.0092 | $2.8798 | -64.52% |
| December, 2027 | $2.4379 | $2.1489 | $2.3384 | -50.55% |
Lyra Therapeutics Inc Stock (LYRA) Price Forecast for 2028
In 2028, Lyra Therapeutics Inc (LYRA) is projected to reach an average price of $5.4876, with a high projection of $10.96 and a low estimate of $0.0118. This indicates an +11.31% rise from the last price of $4.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.2368 | $2.3161 | $2.2476 | -54.63% |
| February, 2028 | $0.9857 | $1.4757 | $1.7602 | -80.01% |
| March, 2028 | $1.5443 | $1.7148 | $1.3154 | -68.68% |
| April, 2028 | $1.9732 | $2.1537 | $1.9037 | -59.98% |
| May, 2028 | $0.8418 | $1.3818 | $1.9329 | -82.92% |
| June, 2028 | $0.6493 | $0.189 | $1.1393 | -86.83% |
| July, 2028 | $0.1004 | $0.0118 | $1.0096 | -97.96% |
| August, 2028 | $1.0118 | $0.0857 | $1.5418 | -79.48% |
| September, 2028 | $2.1529 | $0.9523 | $2.6229 | -56.33% |
| October, 2028 | $1.264 | $0.9737 | $2.7431 | -74.36% |
| November, 2028 | $11.33 | $0.8143 | $6.5394 | +129.81% |
| December, 2028 | $10.27 | $10.65 | $10.96 | +108.26% |
Lyra Therapeutics Inc Stock (LYRA) Price Forecast for 2029
The 2029 price forecast for Lyra Therapeutics Inc Stock (LYRA) is $11.70 on average, with a high prediction of $14.26 and a low estimate of $9.1426. This represents an +137.39% increase from the previous price of $4.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $14.70 | $12.28 | $14.26 | +198.27% |
| February, 2029 | $12.09 | $12.99 | $13.15 | +145.28% |
| March, 2029 | $12.02 | $12.04 | $11.22 | +143.82% |
| April, 2029 | $12.92 | $12.02 | $12.85 | +162.03% |
| May, 2029 | $11.31 | $12.97 | $12.93 | +129.31% |
| June, 2029 | $12.90 | $12.46 | $12.85 | +161.72% |
| July, 2029 | $11.41 | $11.77 | $12.95 | +131.46% |
| August, 2029 | $12.68 | $12.70 | $13.67 | +157.16% |
| September, 2029 | $12.40 | $12.19 | $11.83 | +151.44% |
| October, 2029 | $8.6931 | $9.2231 | $8.3153 | +76.33% |
| November, 2029 | $10.93 | $9.1426 | $10.43 | +121.72% |
| December, 2029 | $11.96 | $11.25 | $10.93 | +142.57% |
Lyra Therapeutics Inc Stock (LYRA) Price Forecast for 2030
Lyra Therapeutics Inc Stock (LYRA) is expected to reach an average price of $12.70 in 2030, with a high forecast of $14.53 and a low forecast of $10.87. This signifies an +157.61% surge from the last price of $4.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.76 | $14.05 | $14.15 | +179.03% |
| February, 2030 | $13.27 | $12.89 | $12.17 | +169.24% |
| March, 2030 | $14.17 | $13.60 | $13.33 | +187.46% |
| April, 2030 | $14.18 | $14.21 | $13.97 | +187.61% |
| May, 2030 | $11.76 | $12.26 | $13.24 | +138.47% |
| June, 2030 | $11.43 | $10.87 | $10.42 | +131.94% |
| July, 2030 | $12.51 | $12.29 | $12.24 | +153.79% |
| August, 2030 | $14.31 | $13.70 | $13.54 | +190.25% |
| September, 2030 | $14.53 | $14.74 | $14.14 | +194.67% |
| October, 2030 | $14.39 | $14.80 | $14.53 | +191.98% |
| November, 2030 | $13.01 | $13.75 | $13.65 | +163.94% |
| December, 2030 | $13.46 | $13.23 | $13.19 | +173.03% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):